The Harapan Kita National Cardiovascular Center (RSJPDHK) is expected to be one of the best heart hospitals in Asia with the support of the newly inaugurated “Ventricle Building,” Deputy Minister of Health, Dante Saksono Harbuwono, said.

At its soft launch here on Wednesday, he reviewed various facilities at the new building.

He said that his party is quite pleased with the supporting facilities at the new building, such as operating rooms for children.

“The operating room for child patients has been added to become 10 operation rooms,” the minister added.

However, the heart transplantation service is not available in Indonesia although the human resources and facilities owned by RSJPDHK are adequate for performing the service, he noted.

“The heart transplantation service will certainly be developed later in this Ventricle Building since, in fact, it already has sufficient (human) resources and facilities,” he said.

The most important thing in heart transplant services is networking, thus later, his party will devise regulations regarding the heart transplant service network, Harbuwono added.

“Because it is not only considering the person who will receive the transplant, but the transplanted heart must still also be in a good condition,” he said.

Heart transplant services will be provided at the RSJPDHK’s new facility in collaboration with University of California Los Angeles (UCLA) Health and the University Medical Center Utrecht.

In addition, RSJPDHK is also trying to build cooperation with the US-based Clifton Clinic. The cooperation agreement between the two parties is targeted to be signed in December 2022.

“Hopefully, the signing (of the cooperation agreement) will increase and improve not only medical engineering, but also operational management at RSJPDHK, thus it will have international capacity and quality,” the minister added.

President director of RSJPDHK, Iwan Dakota, said that in addition to preparing for the health transplantation service, his party has also readied other services, such as stem cell therapy.

Source: Antara News